3d and 4d coordination complexes and coordination polymers involving electroactive tetrathiafulvalene containing ligands

International audienceThe "through bond" approach has been recently developed to increase the interaction between the mobile π and localized d electrons in multifunctional molecular materials involving tetrathiafulvalene-based ligands. This article reviews the 3d and 4d coordination complexes and polymers elaborated from a library of tetrathiafulvalene derivatives containing ligands obtained recently in our group. The different synthetic ways of the complexes are highlighted as well as their chemical and physical properties

Synthesis, Characterization, and Preliminary Study of [Co(2- aminopyridine)2(NCS)2] or bis(2-aminopyridine)dithiocyanato cobalt(II) as An Antibacterial

This study aims to synthesize complex compounds from the Co(II) ion with mixed ligands of 2-aminopyridine and thiocyanate ions. The complexes obtained have Co(II) : 2-aminopyridine: thiocyanate ratio of 1:2:2 based on preliminary analysis by SEM-EDX, DHL, and FTIR. The complex in the form of a blue needle crystal is stable at room temperature and melts at 169 °C. Characterization shows that the complex formed is neutral. The antibacterial activity test was carried out using the diffusion method and show that the resulting complex compounds could inhibit the growth of S. typhi and S. aureus bacteria better than 2-aminopyridine

[Cu(tn)]3[Cr(CN)6]2·3H2O: a unique two-dimensional Cu–Cr cyano-bridged ferromagnet (tn = 1,3-diaminopropane)

Reaction of the two-coordinate ‘assembling complex-ligand’ [Cu(tn)]2+ with the building block [Cr(CN)6]32 leads to a unique two-dimensional Cu–Cr cyano-bridged ferromagnet with unusual m3- and m4-bridging [Cu(tn)]2+ units.Gomez Garcia, Carlos Jose, [email protected]

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis

BACKGROUND: Psoriasis is a chronic immune-mediated inflammatory skin disease affecting both adults and children. To better understand the efficacy-safety profile of biologics in children with moderate-to-severe psoriasis, this study aimed to analyze efficacy and safety data of randomized controlled trials (RCTs) performed in pediatric psoriasis and to compare efficacy outcomes in children with those in adults. METHODS: RCTs investigating biologics in children with moderate-to-severe psoriasis were identified in a systematic literature review. PASI75/90 treatment responses at weeks 11/12 were analyzed comparing biologics with control arms. Serious adverse events (SAEs) were analyzed at the end of each study. Efficacy data from RCTs in adults with psoriasis were selected for the same biologics. Risk ratios (RR) of selected RCTs were pooled together in a statistical random effects model using the inverse variance method. RESULTS: For children, there were 1 etanercept, 2 secukinumab, 1 ixekizumab and 1 ustekinumab placebo-controlled RCTs and 1 adalimumab RCT using methotrexate as reference arm at weeks 11/12. For adults, out of 263 RCTs, 7 adalimumab and 15 etanercept (TNF inhibitors) and 4 ixekizumab and 12 ustekinumab (IL-17 and IL-12/23 inhibitors) RCTs reported PASI75/90 efficacy responses at weeks 11/12. Regarding efficacy, all biologics showed improved PASI responses over control arms. RRs ranges were 2.02-7.45 in PASI75 and 4.10-14.50 in PASI90. The highest PASI75 responses were seen for ustekinumab 0.375 mg/kg (RR = 7.25, 95% CI 2.83-18.58) and ustekinumab 0.75 mg/kg (RR = 7.45, 95% CI 2.91-19.06) in the CADMUS study. The highest PASI90 response was seen for ixekizumab (RR = 14.50, 95% CI 4.82-43.58) in the IXORA-PEDS study. SAE incidences in pediatric and adult arms with biologics were 0 to 3% except for a pediatric arm with adalimumab 0.40 mg/kg (8%). For adults, pooled RR also showed improved PASI responses over placebo for all biologics, with highest PASI75 response observed for ixekizumab (pooled RR = 16.18, 95% CI 11.83-22.14). CONCLUSION: Both adults and children with psoriasis show superior efficacy with biologics compared to control arms after 3 months of treatment with SAE incidences in the low percentages. Additional longer-term clinical studies are warranted to fully understand the overall efficacy-safety profile of biologics in children with moderate-to-severe psoriasis

Melatonin as a Therapy for Preterm Brain Injury: What Is the Evidence?

Despite significant improvements in survival following preterm birth in recent years, the neurodevelopmental burden of prematurity, with its long-term cognitive and behavioral consequences, remains a significant challenge in neonatology. Neuroprotective treatment options to improve neurodevelopmental outcomes in preterm infants are therefore urgently needed. Alleviating inflammatory and oxidative stress (OS), melatonin might modify important triggers of preterm brain injury, a complex combination of destructive and developmental abnormalities termed encephalopathy of prematurity (EoP). Preliminary data also suggests that melatonin has a direct neurotrophic impact, emphasizing its therapeutic potential with a favorable safety profile in the preterm setting. The current review outlines the most important pathomechanisms underlying preterm brain injury and correlates them with melatonin’s neuroprotective potential, while underlining significant pharmacokinetic/pharmacodynamic uncertainties that need to be addressed in future studies

Synthesis, Structure, Magnetic and Antibacterial Properties of polymeric [M(Quin)2(N(CN)2)2]∞ (M = Mn(II), Co(II); Quin = quinoline)

Two complexes of [Mn(Quin)2(N(CN)2)2]∞ (1) and [Co(Quin)2(N(CN)2)2]∞ (2) were synthesized and characterized. The as-synthesized complexes crystallized in a triclinic lattice with a space group of P-1. The unit cell parameter of 1 was a = 7.5207(14) Å, b = 7.7729(16) Å, c = 9.5968(15) Å, α = 96.388(6) o, β = 112.617(5) o, γ = 102.751(6) o, while for complex 2 it was a = 7.3942(10) Å, b = 7.7960(10) Å, c = 9.4907(13) Å, α = 96.631(4) o, β = 112.742(4) o, γ = 102.458(4) o. The magnetic properties and antimicrobial properties of both polymeric complexes were examined by magnetic susceptibility and diffusion techniques, respectively. Complexes 1 and 2 both showed antiferromagnetic properties and had a higher inhibitory effect on the growth of Staphylococcus aureus than Salmonella typhi

A new approach towards ferromagnetic conducting materials based on TTF-containing polynuclear complexes

International audienceFive complexes containing binuclear cation [Cu2(LH)2]2+ (LH2 = 1 : 2 Schiff base of 1,3-diaminobenzene and butanedione monoxime) were prepared and characterized. Metathesis of one perchlorate anion in [Cu2(LH)2(H2O)2](ClO4)2 (1) by anionic TTF-carboxylate (TTF-CO2−) leads to the complex [Cu2(LH)2(CH3OH)2](TTF-CO2)(ClO4)*H2O (2). Reactions of 1 with substituted pyridines bipy, dpe and TTF-CH = CH-py result in formation of the complexes {[Cu2(LH)2(bipy)](ClO4)2}n*2nH2O (3), [Cu2(LH)2(dpe)2](ClO4)2*2CH3OH (4) and [Cu2(LH)2(TTF-CH = CH-py)(H2O)](ClO4)2*1.5H2O (5), where bipy = 4,4′-bipyridine, dpe = trans-(4-pyridyl)-1,2-ethylene and TTF-CH = CH-py = 1-(2-tetrathiafulvalenyl)-2-(4-pyridyl)ethylene. Whereas complex 2 is built from discrete ionic particles (with rather long Cu-S contacts), compounds 1 and 3 contain 1D polymeric chains, in which structural units are bonded through Cu-O bonds or through bridging bipy molecule, respectively. Dinuclear complexes 4 and 5 are linked though π-stacking of dpe or TTF-CH = CH-py, respectively. All complexes are characterized by dominating ferromagnetic behavior with J values in the range from +9.92(8) cm−1 to +13.4(2) cm−1 for Hamiltonian H = -JS1S2. Magnetic properties of the compounds, containing stacks of aromatic molecules in crystal structures (4 and 5), correspond to ferromagnetic intradimer and antiferromagnetic intermolecular interactions (zJ′ = −0.158(3) and −0.290(2) cm−1, respectively). It was found that TTF-CH = CH-py ligand in [Cu2(LH)2(TTF-CH = CH-py)(H2O)]2+ could be electrochemically oxidized to cation-radical form in the solution

Heptanuclear hydroxo-bridged copper cluster of the dicubane-like type: structural and magnetic characterisations of [Cu7(OH)6Cl2(pn)6(H2O)2](C(CN)3)4Cl2 (pn = 1,3-diaminopropane)

A new polynuclear copper(II) complex [Cu7(OH)6Cl2- (pn)6(H2O)2](C(CN)3)4Cl2 with hydroxo-bridging ligands has been prepared; the centrosymmetric cluster cation can be described as two Cu4O3Cl distorted cubane units sharing one copper cation.Clemente Juan, Juan Modesto, [email protected] ; Gomez Garcia, Carlos Jose, [email protected] ; Coronado Miralles, Eugenio, [email protected]

Synthesis, Structure, Magnetic and Antibacterial Properties of polymeric [M(Quin)2(N(CN)2)2]∞ (M = Mn(II), Co(II); Quin = quinoline)

Two complexes of [Mn(Quin)2(N(CN)2)2]∞ (1) and [Co(Quin)2(N(CN)2)2]∞ (2) were synthesized and characterized. The as-synthesized complexes crystallized in a triclinic lattice with a space group of P-1. The unit cell parameter of 1 was a = 7.5207(14) Å, b = 7.7729(16) Å, c = 9.5968(15) Å, α = 96.388(6) o, β = 112.617(5) o, γ = 102.751(6) o, while for complex 2 it was a = 7.3942(10) Å, b = 7.7960(10) Å, c = 9.4907(13) Å, α = 96.631(4) o, β = 112.742(4) o, γ = 102.458(4) o. The magnetic properties and antimicrobial properties of both polymeric complexes were examined by magnetic susceptibility and diffusion techniques, respectively. Complexes 1 and 2 both showed antiferromagnetic properties and had a higher inhibitory effect on the growth of Staphylococcus aureus than Salmonella typhi